As the curtains draw on 2025, the biotechnology sector has emerged as the undisputed champion of the equity markets, staging a dramatic year-end rally that has caught even the most optimistic analysts by surprise. After years of trading in the shadow of high interest rates and regulatory uncertainty, the industry
As the sun sets on a tumultuous yet transformative 2025, the financial markets are entering their final trading sessions with a sense of quiet confidence. As of December 22, 2025, the S&P 500 (NYSE: SPY) is navigating the traditional "Santa Claus Rally" period with characteristic low volume, yet it
Miran stated that while he does not see a recession right now, the neutral rate of interest has been brought down because of a “variety of shocks” to the U.S. economy.
Gold’s rally appears structurally supported, with JPMorgan projecting further upside on sustained central-bank and ETF demand, while silver’s outlook remains more cyclical, potentially moderating if industrial demand—especially from solar—softens in 2026.
Friday brought another constructive “repair” day after Thursday’s bounce: advancers stayed in control, 4% winners expanded, and new highs continued to outpace new lows. Still, the bigger picture remains mixed, weekly breadth is still tilted to decliners and the 3-month ledger remains slightly negative, suggesting this rebound needs follow-through to become a durable trend.
As the trading calendar winds down to its final pages, investors on Wall Street are positioning themselves for what has historically been one of the most reliable seasonal patterns in finance: the "Santa Claus Rally." With the S&P 500 (NYSE: SPY) hovering near record highs and a fresh interest
Wall Street received an early holiday gift this week as the U.S. Bureau of Labor Statistics released a Consumer Price Index (CPI) report that significantly undercut analyst expectations, signaling a definitive cooling in the inflationary pressures that have dogged the economy for years. On December 18, 2025, the headline
Although revenue growth has cooled, both Hilton and Marriott have continued to beat revenue and profit estimates in recent quarters while rolling out ambitious expansion plans.
After Wednesday’s heavy selling, Thursday delivered a clear breadth rebound: advancers retook control and the “big down” day count normalized. But zooming out, the market is still working through short-term damage, weekly breadth remains skewed to decliners and the major ETFs are still battling key moving averages and overhead supply.
NEW YORK — As the final trading days of 2025 approach, the financial world finds itself at a critical juncture. On December 18, 2025, a cooler-than-expected Consumer Price Index (CPI) report—showing inflation at a multi-year low of 2.7%—has sent a surge of optimism through Wall Street. This data
